Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Federation Of European Scleroderma Association

FESCA is the Federation of European Scleroderma Associations, a one of a kind connection among European scleroderma care groups all through the European Union. Established in February 2007, FESCA as of now has 16 part assembles and incorporates patient associations from Belgium, Cyprus, Denmark, Germany, France, Hungary, Ireland, Italy, the Netherlands, Portugal, Spain, Switzerland, and the United Kingdom. Their central goal is to represent the interests of the individuals who have scleroderma, otherwise called systemic sclerosis. Their principle point is to promote the advancement of knowledge, research, and information in the field of scleroderma inside medical, governmental, and social fields, and to build attention to the infection among the overall population.

Federation of European Scleroderma Associations (FESCA) acts at a pan-European level to advance and accomplish its goals in arrangement with the points of the national groups it represents. As an umbrella gathering, FESCA bolsters its part associations, while the backing of individual sufferers of scleroderma remains the sole dispatch of national associations.

FESCA's destinations incorporate empowering the dynamic contribution of legislators and pharmaceutical organizations, working with specialists to secure prior diagnosis and better medications, and making more prominent consciousness of scleroderma so that the individuals who experience the ill effects of it can get to appropriate, equitable care. To do this, FESCA encourages cooperation among national relationship to share thoughts and activities, and works towards the advancement of a political, social, and medicinal environment that encourages the accomplishment of the FESCA vision.

Read More»